<VariationArchive RecordType="classified" VariationID="268124" VariationName="NM_018263.6(ASXL2):c.1225_1228del (p.Pro409fs)" VariationType="Deletion" Accession="VCV000268124" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-11" DateCreated="2016-11-14" MostRecentSubmission="2016-11-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="263650" VariationID="268124">
      <GeneList>
        <Gene Symbol="ASXL2" FullName="ASXL transcriptional regulator 2" GeneID="55252" HGNC_ID="HGNC:23805" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25733753" stop="25878487" display_start="25733753" display_stop="25878487" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25962252" stop="26101311" display_start="25962252" display_stop="26101311" Strand="-" />
          </Location>
          <OMIM>612991</OMIM>
          <Haploinsufficiency last_evaluated="2018-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_018263.6(ASXL2):c.1225_1228del (p.Pro409fs)</Name>
      <CanonicalSPDI>NC_000002.12:25750327:TTGGTTG:TTG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25750328" stop="25750331" display_start="25750328" display_stop="25750331" variantLength="4" positionVCF="25750327" referenceAlleleVCF="TTTGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25973197" stop="25973200" display_start="25973197" display_stop="25973200" variantLength="4" positionVCF="25973196" referenceAlleleVCF="TTTGG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P409fs</ProteinChange>
      <ProteinChange>P149fs</ProteinChange>
      <ProteinChange>P351fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.25973200_25973203del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.25973200_25973203del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.25750331_25750334del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.25750331_25750334del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052995.1" sequenceAccession="NG_052995" sequenceVersion="1" change="g.133186_133189del">
            <Expression>NG_052995.1:g.133186_133189del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369346.1" sequenceAccession="NM_001369346" sequenceVersion="1" change="c.1051_1054del">
            <Expression>NM_001369346.1:c.1051_1054del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356275.1" sequenceAccession="NP_001356275" sequenceVersion="1" change="p.Pro351fs">
            <Expression>NP_001356275.1:p.Pro351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369347.1" sequenceAccession="NM_001369347" sequenceVersion="1" change="c.445_448del">
            <Expression>NM_001369347.1:c.445_448del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356276.1" sequenceAccession="NP_001356276" sequenceVersion="1" change="p.Pro149fs">
            <Expression>NP_001356276.1:p.Pro149fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018263.6" sequenceAccession="NM_018263" sequenceVersion="6" change="c.1225_1228del" MANESelect="true">
            <Expression>NM_018263.6:c.1225_1228del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060733.4" sequenceAccession="NP_060733" sequenceVersion="4" change="p.Pro409fs">
            <Expression>NP_060733.4:p.Pro409fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1421" sequenceAccession="LRG_1421">
            <Expression>LRG_1421:g.133186_133189del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1421t1" sequenceAccession="LRG_1421t1">
            <Expression>LRG_1421t1:c.1225_1228del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1421p1" sequenceAccession="LRG_1421p1" change="p.Pro409fs">
            <Expression>LRG_1421p1:p.Pro409fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10602664" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612991.0003" DB="OMIM" />
        <XRef Type="rs" ID="886041067" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018263.6(ASXL2):c.1225_1228del (p.Pro409fs) AND Shashi-Pena syndrome" Accession="RCV000258843" Version="2">
        <ClassifiedConditionList TraitSetID="33247">
          <ClassifiedCondition DB="MedGen" ID="C4310672">Shashi-Pena syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-11-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-11-14" MostRecentSubmission="2016-11-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27693232</ID>
        </Citation>
        <DescriptionHistory Dated="2016-11-17">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33247" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36317" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Shashi-Pena syndrome</ElementValue>
                <XRef ID="MONDO:0014963" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SHAPNS</ElementValue>
                <XRef Type="MIM" ID="617190" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310672" DB="MedGen" />
              <XRef ID="MONDO:0014963" DB="MONDO" />
              <XRef Type="MIM" ID="617190" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="628514" SubmissionDate="2016-11-11" DateLastUpdated="2016-11-14" DateCreated="2016-11-14">
        <ClinVarSubmissionID localKey="612991.0003_SHASHI-PENA SYNDROME" title="ASXL2, 4-BP DEL, 1225CCAA_SHASHI-PENA SYNDROME" />
        <ClinVarAccession Accession="SCV000328579" DateUpdated="2016-11-14" DateCreated="2016-11-14" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient (patient 3) with Shashi-Pena syndrome (SHAPNS; 617190), Shashi et al. (2016) identified a de novo heterozygous 4-bp deletion (c.1225_1228delCCAA, NM_018263.4) in the second to last exon (exon 10) of the ASXL2 gene, resulting in a frameshift and premature termination (Pro409AsnfsTer13). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was filtered against the dbSNP (build 138), 1000 Genomes Project, Exome Variant Server, and ExAC databases. Analysis of patient cells showed that the mutant transcript was expressed and not subject to nonsense-mediated mRNA decay, providing support for a dominant-negative effect rather than haploinsufficiency. Additional functional studies were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">27693232</ID>
              </Citation>
              <XRef DB="OMIM" ID="617190" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL2" />
          </GeneList>
          <Name>ASXL2, 4-BP DEL, 1225CCAA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 1225CCAA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612991.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SHASHI-PENA SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="628514" TraitType="Disease" MappingType="Name" MappingValue="SHASHI-PENA SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C4310672" Name="Shashi-Pena syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

